美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

KraneShares China Alpha Index ETF

33.32

+0.17500.53%

盤後：33.320.0049+0.01%16:10 EDT

成交量：325

成交額：1.09萬

市值：333.17萬

市盈率：- -

高：33.32

開：33.32

低：33.32

收：33.14

52周最高：40.84

52周最低：30.00

股本：10.00萬

流通股本：10.00萬

量比：0.62

換手率：0.32%

股息：10.72

股息率：32.17%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

港股收評：恒指跌0.38% 科指跌1.61% 科網股跌多漲少石油股持續走高江波龍上市首日破發

港股異動 | 映恩生物-B(09606)尾盤升逾4% 與羅氏合作BD新突破潛在里程碑金額超10億美元

港股海光芯正午後持續走強，尾盤一度漲近40%。

港股石油股尾盤漲幅進一步擴大

每日经济新闻

港股異動 | 科拓股份(02272)尾盤漲幅擴逾10% 日前獲納入港股通智慧停車龍頭解鎖內地通道

港股異動 | 煤炭股午後漲幅擴大安監從民營礦拓展至國企或使供給約束更具持續性

港股異動 | 丹諾醫藥-B(06872)升逾7% 日前獲納入港股通名單利福喹酮IIa期概念驗證數據積極

港股異動 | 中國海外宏洋集團(00081)升逾5% 前8個月累計合約銷售額按年上升17.5%

港股煤炭股午後漲幅擴大，截至發稿，力量發展漲4.37%，報2.03港元；中煤能源漲2.90%，報11.37港元；兗礦能源

港股異動 | 博彩股集體回暖澳門賭收按年連跌三月機構看好9月按年增長6%

港股海光芯正升逾10%

每日经济新闻

港股異動 | 華曦達(00901)升逾5% 公司納入恒生綜合指數成份股及入通落地邊緣AI概念落地迎關鍵臨界點

市場消息：摩爾線程秘密遞交港股上市申請。

智譜港股跌超11%

港股異動 | 百奧賽圖-B(02315)午後升逾10% 與齊魯製藥簽署全人納米抗體分子非排他授權合作協議

南下資金淨買入港股超50億港元。

港股異動 | CRO概念股震盪走高企業在手訂單呈「量價齊升」 AI製藥有望重塑醫藥研發業態

港股異動 | 基石藥業-B(02616)午後升逾6% 獲納入港股通標的證券名單國際大行相繼看好公司發展前景

港股生物醫藥股午後走強，劑泰科技-P漲近15%，百奧賽圖-B、金斯瑞生物科技漲近10%

老虎资讯综合

港股生物技術板塊午後拉升

南方财经网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KCAI/news?page=28"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KCAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCAI\",,,,,undefined,":{"symbol":"KCAI","market":"US","secType":"STK","nameCN":"KraneShares China Alpha Index ETF","latestPrice":33.315,"timestamp":1789761600000,"preClose":33.14,"halted":0,"volume":325,"hourTrading":{"tag":"盘后","latestPrice":33.3199,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":200.04,"timestamp":1789762204041,"change":0.0049,"changeRate":0.000147,"amplitude":0},"delay":0,"changeRate":0.005280627640313735,"floatShares":100005,"shares":100005,"eps":0,"marketStatus":"休市中","change":0.175,"latestTime":"09-18 16:00:00 EDT","open":33.32,"high":33.32,"low":33.315,"amount":10856,"amplitude":0.000151,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.14,"sharesOutstanding":250002,"nav":33.22,"aum":3321711.73,"dividendRate":0.321651,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.3199,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":200.04,"timestamp":1789762204041,"change":0.0049,"changeRate":0.000147,"amplitude":0},"volumeRatio":0.624039758821114},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KCAI\",,,,,undefined,":{"symbol":"KCAI","floatShares":100005,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.624039758821114,"shares":100005,"dividePrice":10.7158,"high":33.32,"amplitude":0.000151,"preClose":33.14,"low":33.315,"week52Low":30,"pbRate":"--","week52High":40.84,"institutionHeld":0,"latestPrice":33.315,"eps":0,"divideRate":0.321651,"volume":325,"delay":0,"ttmEps":0,"open":33.32,"prevYearClose":30.48,"prevWeekClose":33.22,"prevMonthClose":33.259,"prevQuarterClose":32.15,"fiveDayClose":33.22,"twentyDayClose":32.9701,"sixtyDayClose":31.815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KCAI\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"KCAI","amount":0.080552,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2025-12-22","symbol":"KCAI","amount":10.716664,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KCAI","amount":0.59272,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares China Alpha Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KCAI\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-18","value":0.59272,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-23","value":10.716664,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.080552,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KCAI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KCAI\",pageSize:20,pageCount:28,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665268323","title":"港股收評：恒指跌0.38% 科指跌1.61% 科網股跌多漲少 石油股持續走高 江波龍上市首日破發","url":"https://stock-news.laohu8.com/highlight/detail?id=2665268323","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665268323?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:00","pubTimestamp":1788854400,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数跌0.38%，报25317.18，恒生科技指数跌1.61%，国企指数跌0.38%。江波龙上市首日跌超1%。石油股持续走高，中海油田服务涨超6%。沙特能源部称，正努力确保设施安全、人员平安及运营的连续性。创新药概念多数上涨，金斯瑞生物科技涨超11%。此次上市正值存储行业景气高点。招股书披露，2026年上半年江波龙实现收入240.88亿元，同比增长136.3%，毛利率由上年同期的11.0%升至58.2%，期内利润107.18亿元，而上年同期仅为0.41亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-08/doc-inirceww9421481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["513600","OILK","OILT","XLE","09976","07200","OIH","KCAI","82800","MCHmain","07500","HSI","BNO","IXC","XOP","GUSH","03419","VXUS","PXJ","DRLL","WTIU","159019","02800","DRIP","ERX","DIG","PXE","XES","MHImain","IEO","BK4585","03037","03115","HSImain","02833","USL","USE","DBC","DBE","USOI","301308","83115","HHImain","07300","IPOS","FTXN","09115","OILU","BK4588","VDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432393","title":"港股異動 | 映恩生物-B(09606)尾盤升逾4% 與羅氏合作BD新突破 潛在里程碑金額超10億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432393","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432393?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:58","pubTimestamp":1788854320,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B尾盘涨超4%。截至发稿，涨3.56%，报186.4港元，成交额1.94亿港元。消息面上，近日，映恩生物与罗氏集团旗下Genentech签署合作许可协议，依托公司DUPAC平台开发多款肿瘤适应症下一代ADC药物。根据合作协议，映恩生物将收取4500万美元的首付款，并有资格就所有合作项目收取总额超过10亿美元的潜在开发、监管及商业化里程碑付款。同时，公司已与多家全球药企达成合作，首付款、里程碑付款及潜在销售分成有望构成长期收入来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","KCAI","BK4588","VXUS","HK0000252160.HKD","BK4585","HK0000500386.USD","BK1161","LU2543165471.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862323","title":"港股海光芯正午後持續走強，尾盤一度漲近40%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862323?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:49","pubTimestamp":1788853782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VXUS","BK4588","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323593","title":"港股石油股尾盤漲幅進一步擴大","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323593","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323593?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:48","pubTimestamp":1788853680,"startTime":"0","endTime":"0","summary":"9月8日，石油股尾盘涨幅进一步扩大，截至发稿，中海油田服务(02883.HK)涨6.20%，报7.62港元；中国海洋石油(00883.HK)涨4.10%，报25.9港元；中国石油股份(00857.HK)涨3.71%，报10.33港元；中国石油化工股份(00386.HK)涨3.60%，报4.895港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083868029855.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083868029855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PXJ","PXE","BK4585","IXC","BK4588","XLE","BK4570","XES","OILU","XOP","OILK","DBE","OIH","OILT","ERX","FTXN","VXUS","159019","DIG","USOI","DRLL","IEO","USE","USL","WTIU","VDE","GUSH","KCAI","DRIP","BNO","DBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665032328","title":"港股異動 | 科拓股份(02272)尾盤漲幅擴逾10% 日前獲納入港股通 智慧停車龍頭解鎖內地通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2665032328","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665032328?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:37","pubTimestamp":1788853042,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科拓股份(02272)今日震荡走高，尾盘涨幅扩逾10%。截至发稿，涨9.6%，报90.8港元，成交额约819.18万港元。消息面上，9月7日起，科拓股份正式获调入港股通标的证券名单。这意味着内地投资者自此可通过沪深港通直接买卖科拓股份，正式解锁南向资金。今年上半年，公司取得收益3.34亿元人民币，经调整纯利2866.7万元，持续加大停车场运营业务投入。展望未来，科拓股份将持续深化停车场运营业务，扩大承包运营模式规模并拓展在线车位租赁平台，进一步释放停车场资产的变现潜力。公司亦将持续拓宽地理覆盖范围，加速AI赋能解决方案全面部署。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","KCAI","BK4588","BK1179","BK4585","FLHK","02272"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665288643","title":"港股異動 | 煤炭股午後漲幅擴大 安監從民營礦拓展至國企 或使供給約束更具持續性","url":"https://stock-news.laohu8.com/highlight/detail?id=2665288643","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665288643?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:07","pubTimestamp":1788851221,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，煤炭股午后涨幅扩大，截至发稿，力量发展涨4.37%，报2.03港元；中煤能源涨2.90%，报11.37港元；兖矿能源涨2.24%，报13.25港元；中国神华涨1.88%，报45.5港元。华泰证券认为，84号文的出台意味着5·22以来强化的一系列安监措施有望由阶段性整治逐步转向常态化约束，考虑到国有煤企是国内煤炭稳产保供的重要主体，中期供给弹性或进一步下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161032","BK4585","BK4588","KCAI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340203","title":"港股異動 | 丹諾醫藥-B(06872)升逾7% 日前獲納入港股通名單 利福喹酮IIa期概念驗證數據積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340203","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340203?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:04","pubTimestamp":1788851053,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹诺医药-B涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。丹诺医药专注于细菌感染及细菌代谢相关疾病领域。9月7日，丹诺医药公布，利福喹酮治疗人工关节感染的IIa期概念验证临床取得积极结果，多中心IIb期试验已启动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","06872","BK4585","KCAI","BK4588","BK1161","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340749","title":"港股異動 | 中國海外宏洋集團(00081)升逾5% 前8個月累計合約銷售額按年上升17.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340749","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340749?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:01","pubTimestamp":1788850899,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国海外宏洋集团涨超5%，截至发稿，涨4.65%，报2.925港元，成交额1567.95万港元。消息面上，中国海外宏洋集团发布公告，在2026年8月份，中海宏洋系列公司实现合约销售额人民币23.48亿元及合约销售面积19.91万平方米，分别按年上升10.1%及下跌2.0%。在2026年1至8月份，累计合约销售额人民币244.21亿元及合约销售面积209.41万平方米，分别按年上升17.5%及12.3%。截至2026年8月底，累计认购未签约额人民币5.75亿元及认购未签约面积4.44万平方米。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0702159699.USD","LU1166156734.SGD","BK1555","LU0702159343.USD","VXUS","BK4585","00081","BK4588","BK1240","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340645","title":"港股煤炭股午後漲幅擴大，截至發稿，力量發展漲4.37%，報2.03港元；中煤能源漲2.90%，報11.37港元；兗礦能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340645","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:56","pubTimestamp":1788850578,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["EWH","BK4585","BK4588","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340646","title":"港股異動 | 博彩股集體回暖 澳門賭收按年連跌三月 機構看好9月按年增長6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340646?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:54","pubTimestamp":1788850467,"startTime":"0","endTime":"0","summary":"消息面上，澳门博彩监察协调局近日公布，8月赌收218.9亿澳门元，按年跌1.2%，连跌第三个月，按月则续回升8.1%。首8个月计，澳门博彩收入按年升3.7%至1690.5亿澳门元。海通国际发表研究报告指，澳门8月赌收按年下降1.2%，略低于市场预期。该行指出，暑期旺季延续带动市场回暖，海通国际预计9月行业赌收将按年增长6%，恢复至2019年的87.8%，主要受去年同期台风扰动，娱乐场关闭33小时带来的低基数影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","BK4588","LU1224709979.USD","LU1328615791.USD","LU0326950275.SGD","00880","LU0149534421.HKD","LU1166156734.SGD","LU1048596156.SGD","02282","BK4585","KCAI","LU0348784397.USD","LU0737861699.HKD","LU0650527681.SGD","LU0702159699.USD","LU1880383366.USD","LU0140636845.USD","LU0307460666.USD","LU0348783233.USD","HK0000288784.HKD","LU0594300419.USD","BK1589","LU1282649810.SGD","00027","LU0173614495.USD","LU0593848301.USD","LU1282649067.USD","LU0287142896.SGD","LU0821914370.USD","00200","LU0384037296.USD","LU0211977185.USD","VXUS","LU0588546209.SGD","BK1610","HK0000288743.USD","LU0488056044.USD","LU2039709279.SGD","LU0607220059.USD","LU0417516571.SGD","BK1172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665905340","title":"港股海光芯正升逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665905340","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665905340?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:50","pubTimestamp":1788850239,"startTime":"0","endTime":"0","summary":"港股海光芯正涨超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083867998561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083867998561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KCAI","VXUS","01191","BK4585","BK1147","BK1537","BK4588","BK1170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340693","title":"港股異動 | 華曦達(00901)升逾5% 公司納入恒生綜合指數成份股及入通落地 邊緣AI概念落地迎關鍵臨界點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340693","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:43","pubTimestamp":1788849824,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华曦达涨超5%，截至发稿，涨5.11%，报72港元，成交额1518.48万港元。消息面上，近日，华曦达获恒生指数有限公司选定，将纳入恒生综合指数成份股，自2026年9月7日起生效，标志着公司资本市场建设迈出关键一步。与此同时，自9月7日起公司获调入沪港通下港股通标的。华曦达此前披露2026年中期业绩公告，上半年公司实现收入人民币20.95亿元，同比增长36.3%；期内溢利人民币1.81亿元，同比增长75.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","ARTY","00901","BK4585","BK1193","KCAI","BK4588","QTOC","BK1156","VTHR","VXUS","AGIX","AIPO","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665834714","title":"市場消息：摩爾線程秘密遞交港股上市申請。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665834714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665834714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:20","pubTimestamp":1788848410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","IPOS","VXUS","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665334763","title":"智譜港股跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665334763","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665334763?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:12","pubTimestamp":1788847972,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665934210","title":"港股異動 | 百奧賽圖-B(02315)午後升逾10% 與齊魯製藥簽署全人納米抗體分子非排他授權合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2665934210","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665934210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:53","pubTimestamp":1788846789,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B午后涨超10%，截至发稿，涨8.71%，报63港元，成交额1.29亿港元。消息面上，据百奥赛图官微消息，公司宣布近期与齐鲁制药签署全人纳米抗体分子非排他授权合作协议。本次合作涉及的纳米抗体分子由百奥赛图自主研发的RenNano纳米抗体平台产生。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1191","BK4585","BK4588","688796","KCAI","BK1161","02315","BK1574","VXUS","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342930","title":"南下資金淨買入港股超50億港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342930","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342930?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:46","pubTimestamp":1788846400,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","KCAI","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665996342","title":"港股異動 | CRO概念股震盪走高 企業在手訂單呈「量價齊升」 AI製藥有望重塑醫藥研發業態","url":"https://stock-news.laohu8.com/highlight/detail?id=2665996342","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665996342?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:43","pubTimestamp":1788846222,"startTime":"0","endTime":"0","summary":"分析指出，AI辅助新药研发已不止于概念，而真正可以支撑原创药物从发现走向临床，直至上市。招商证券研报指出，CXO板块景气度明确上行。今年上半年国内CXO板块营收、归母净利润同比分别增长24.5%、52.7%，利润增速接近上一轮周期高点；在手订单与新签订单全面回暖，龙头上调全年指引。此外，AI制药有望重塑医药研发业态，提升药物研发效率，板块亦将受益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","HK0000320264.USD","KCAI","BK1191","BK1576","JHMH","BK1583","CHAT","03347","BK4588","ARTY","01548","AGIX","QTOC","HK0000320223.HKD","BME","HK0000306701.USD","06821","AIPO","BK1141","03759","LRND","VTHR","HK0000306685.HKD","BK4585","VXUS","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665426603","title":"港股異動 | 基石藥業-B(02616)午後升逾6% 獲納入港股通標的證券名單 國際大行相繼看好公司發展前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2665426603","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665426603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:41","pubTimestamp":1788846117,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B午后涨超6%，截至发稿，涨5.27%，报6.385港元，成交额8209.73万港元。消息面上，基石药业-B发布公告，本公司发行并于香港联合交易所有限公司上市的股份获纳入港股通标的证券名单，自2026年9月7日起生效。其中，高盛预计，未来6至12个月将是基石药业关键催化剂密集兑现的阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02616","BK4585","BK1574","KCAI","BK4588","FLHK","VXUS","161027","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113703587","title":"港股生物醫藥股午後走強，劑泰科技-P漲近15%，百奧賽圖-B、金斯瑞生物科技漲近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113703587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113703587?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:33","pubTimestamp":1788845625,"startTime":"0","endTime":"0","summary":"9月8日，港股$生物(000504)$医药股午后走强，$剂泰科技-P(07666)$涨近15%，$百奥赛图-B(02315)$、$金斯瑞生物科技(01548)$涨近10%，$泰格医药(03347)$、$康希诺生物(06185)$、$云顶新耀(01952)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XBI","07666","688796","BK1576","161726","VXUS","HK0000320223.HKD","BK1515","BK1161","03347","HK0000306685.HKD","09939","01548","399441","HK0000306701.USD","BK1583","BK1574","06185","BK1191","HK0000320264.USD","01952","BK4581","KCAI","BK0216","BK1141","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665426123","title":"港股生物技術板塊午後拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2665426123","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665426123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845460,"startTime":"0","endTime":"0","summary":"南方财经9月8日电，港股生物技术板块午后拉升，剂泰科技涨近13%，百奥赛图涨超8%，云顶新耀、基石药业涨超4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083867927161.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083867927161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","KCAI","BK4588","BK4585","HELX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":34,"pageCount":28,"totalSize":674,"code":"91000000","status":"200"}]}}